These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1355970)

  • 21. Positron emission tomography studies of brain receptors.
    Mazière B; Mazière M
    Fundam Clin Pharmacol; 1991; 5(1):61-91. PubMed ID: 1676695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mayo Seminars in Psychiatry: dopamine and schizophrenia--a review.
    Fredrickson P; Richelson E
    J Clin Psychiatry; 1979 Sep; 40(9):399-405. PubMed ID: 39063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
    Buchsbaum MS; Potkin SG; Marshall JF; Lottenberg S; Teng C; Heh CW; Tafalla R; Reynolds C; Abel L; Plon L
    Neuropsychopharmacology; 1992 May; 6(3):155-63. PubMed ID: 1599606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decline of dopamine: effects of age and acute neuroleptic challenge.
    Lieberman JA; Mailman R
    Am J Psychiatry; 1998 Mar; 155(3):319-23. PubMed ID: 9501739
    [No Abstract]   [Full Text] [Related]  

  • 25. Addiction: brain mechanisms and their treatment implications.
    Nutt DJ
    Lancet; 1996 Jan; 347(8993):31-6. PubMed ID: 8531549
    [No Abstract]   [Full Text] [Related]  

  • 26. Molecular pathology of schizophrenia: more than one disease process?
    Crow TJ
    Br Med J; 1980 Jan; 280(6207):66-8. PubMed ID: 6101544
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences.
    Wong DF; Broussolle EP; Wand G; Villemagne V; Dannals RF; Links JM; Zacur HA; Harris J; Naidu S; Braestrup C
    Ann N Y Acad Sci; 1988; 515():203-14. PubMed ID: 2966605
    [No Abstract]   [Full Text] [Related]  

  • 28. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
    Seeman P
    Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated D2 dopamine receptors in drug-naïve schizophrenics.
    Zeeberg BR; Gibson RE; Reba RC
    Science; 1988 Feb; 239(4841 Pt 1):789-91. PubMed ID: 2963379
    [No Abstract]   [Full Text] [Related]  

  • 30. Positron emission tomography in schizophrenia: a new perspective.
    Patel NH; Vyas NS; Puri BK; Nijran KS; Al-Nahhas A
    J Nucl Med; 2010 Apr; 51(4):511-20. PubMed ID: 20237027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of positron emission tomography in psychiatry.
    Parsey RV; Mann JJ
    Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine D2 receptors in schizophrenia studied in vivo.
    Crawley JC; Owens DG; Crow TJ; Poulter M; Johnstone EC; Smith T; Oldland SR; Veall N; Owen F; Zanelli GD
    Lancet; 1986 Jul; 2(8500):224-5. PubMed ID: 2873471
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis.
    Farde L; Eriksson L; Blomquist G; Halldin C
    J Cereb Blood Flow Metab; 1989 Oct; 9(5):696-708. PubMed ID: 2528555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The metabolically disordered neuron].
    Woelk H
    Med Klin; 1979 Oct; Suppl():6-9. PubMed ID: 44343
    [No Abstract]   [Full Text] [Related]  

  • 35. Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primates.
    Innis RB; Malison RT; al-Tikriti M; Hoffer PB; Sybirska EH; Seibyl JP; Zoghbi SS; Baldwin RM; Laruelle M; Smith EO
    Synapse; 1992 Mar; 10(3):177-84. PubMed ID: 1532675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
    Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
    J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography scans in schizophrenia.
    Pal H; Saxena S
    Natl Med J India; 1994; 7(2):74. PubMed ID: 8019402
    [No Abstract]   [Full Text] [Related]  

  • 38. Positron emission tomography in psychiatry.
    Wiesel FA
    Psychiatr Dev; 1989; 7(1):19-47. PubMed ID: 2529539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.